We are live on
!
Find out more
CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
142 hedge funds and large institutions have $907M invested in Cymabay Therapeutics in 2019 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 35 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
98% more capital invested
Capital invested by funds: $458M → $907M (+$449M)
90% more call options, than puts
Call options by funds: $1.62M | Put options by funds: $852K
73% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 15
37% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 35
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
8% more funds holding
Funds holding: 131 → 142 (+11)
Holders
142
Holders Change
+11
Holders Change %
+8.4%
% of All Funds
3.07%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
26
Increased
48
Reduced
35
Closed
15
Calls
$1.62M
Puts
$852K
Net Calls
+$766K
Net Calls Change
+$970K
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$19.9M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$19.3M |
| 3 |
PA
Perceptive Advisors
New York
|
+$18.6M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$14.7M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
+$12.2M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$10.6M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
-$8.98M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$6.5M |
| 4 |
NC
Nexthera Capital
New York
|
-$5.37M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.52M |
